Ocular Therapeutics Sustained Release TKI Trial
Retina Synthesis - A podcast by Retina Synthesis
Categories:
We review the current status of the Ocular Therapeutics TKI sustained release delivery system for treatment of neovascular AMD with Dr. Andrew Moshfeghi, Associate Professor of Ophthalmology USC Roski Eye Institute.
